NCT06231680 2024-03-29Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)Henan Cancer HospitalPhase 2 Unknown132 enrolled
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT00041808 2005-06-24Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverFeRxPhase 1/2 Completed20 enrolled